产品介绍：
产品说明
生化/生理作用
Vandetanib is an orally active and potent inhibitor of vascular endothelial growth factor receptor receptor 2 (VEGFR2) kinase activity that is used to treat medullary thyroid cancer. Vandetanib also inhibits epidermal growth factor receptor (EGFR), and RET tyrosine kinases.
基本信息
| 经验(实验)分子式 | C22H24BrFN4O2 |
| 分子量 | 475.35 |
| MDL编号 | MFCD07772346 |
产品性质
| 质量水平 | 100 |
| 测定 | ≥98% (HPLC) |
| 形式 | powder |
| 颜色 | white to beige |
| 溶解性 | DMSO: 2 mg/mL, clear |
| 储存温度 | 2-8℃ |
安全信息
| 象形图 |    |
| 警示用语： | Warning |
| 危险声明 | H302 - H361d - H373 - H410 |
| 预防措施声明 | P201 - P202 - P260 - P273 - P301 + P312 - P308 + P313 |
| 危险分类 | Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Repr. 2 - STOT RE 2 |
| 靶器官 | Gastrointestinal tract |
| 储存分类代码 | 11 - Combustible Solids |
| WGK | WGK 3 |
| 闪点(F) | Not applicable |
| 闪点(C) | Not applicable |
